Menopur (menotropins)

Combined FSH and LH activity during stimulation

Updated weekly · checked 3 h ago
$95lowest posted cash price per 75 IU vial
$252.12per vial, what pharmacies pay
2,088FAERS reports (all-time)

Menopur costs $95 per 75 IU vial at Mandell's Clinical Pharmacy, the one source we found that posts a cash price (prices read Oct 4, 2026); Ferring HeartTomorrow sells it for $72.75 per 75 IU vial for elective egg freezing cycles paid in cash; a drug-price guide lists $258.05 per 75 IU vial at an ordinary retail pharmacy; pharmacies themselves pay a national average of $252.12 per vial to acquire it (CMS NADAC).

Human menopausal gonadotropin, a purified urinary preparation carrying both FSH and LH activity. Often added to a recombinant FSH stimulation to supply the LH component, particularly for patients whose response to FSH alone is limited.

Cost

What Menopur costs, by pharmacy

Every cash price we found posted by a pharmacy, TrumpRx.gov or the manufacturer, read on the seller's own page on Oct 4, 2026, compared per one unit and cheapest first. A retail drug-price guide's figure is shown for context.

Where, and the product as listedPer 75 IU vial
  • Ferring HeartTomorrowManufacturer program
    Menopur 75 IU vial: MENOPUR for $72.75/vial
    Elective egg freezing cycles only (not IVF or embryo cycles), paid in cash; first fill at least 20 vials; offer ends December 31, 2026.
    $72.75
    read Oct 4, 2026
  • Mandell's Clinical PharmacyFertility pharmacy
    Menopur 75 IU vial: $ 95
    Estimate; service fee added at checkout.
    $95
    read Oct 4, 2026
  • Drugs.com price guideRetail price guide
    Menopur 75 IU, 5 vials: $1,290.23 for 5 ($258.05 per unit)
    $258.05
    read Oct 4, 2026

Cash prices only: with insurance that covers fertility drugs you pay your plan's share instead, and most manufacturer programs cannot be combined with insurance. Prices change; each row links to the page it was read on. Compare every IVF medication, or see what a whole cycle's drugs cost after TrumpRx.

Savings

Programs that lower the cost of Menopur

Each program's own terms, read on its page. Eligibility is the program's to decide.

  • A rebate on Ferring fertility medications, including Menopur, at Ferring's in-network pharmacies. Ferring does not publish the amount.

    Who qualifies: Patients with no fertility coverage of any kind, or whose pharmacy fertility benefit is fully used; not for anyone covered by a federal health program, a co-pay coupon or an employer fertility benefit.

    How to enroll: Nothing to file: the in-network pharmacy checks eligibility when it fills the Menopur prescription.

    Read Oct 4, 2026

  • Menopur at $72.75 per vial, with a first fill of at least 20 vials. The coupon lasts 30 days; the offer ends December 31, 2026.

    Who qualifies: Elective egg freezing only (not IVF or frozen embryo cycles), 18 or older, US resident, paying cash, not in a federal or state health program.

    How to enroll: Patient and prescriber sign the application, which goes to a HEART network pharmacy that receives the coupon.

    Read Oct 4, 2026

  • Heart BeatFerring

    Select Ferring fertility medications, including Menopur, at no cost.

    Who qualifies: Women with a cancer diagnosis who are US citizens or permanent residents and have had no chemotherapy in the previous 12 months, when their doctors judge fertility preservation medically appropriate.

    How to enroll: The fertility team sends the form and prescription to Walgreens specialty pharmacy (Mandell's for Arkansas, Massachusetts and New Jersey). On October 4, 2026 both application links on menopur.com showed an error; Ferring's line is 1-888-337-7464.

    Read Oct 4, 2026

  • Menopur, Endometrin and Novarel 5,000 units at no cost; other medications are not covered.

    Who qualifies: Veterans medically separated from active duty (Department of Defense category 2 or 3) with a service-related injury causing infertility that needs assisted reproduction, or their spouses, with no insurance coverage for IVF medications; residents of the 50 states and DC.

    How to enroll: The physician certifies eligibility and faxes the enrollment form to MDR specialty pharmacy, which ships the medication free.

    Read Oct 4, 2026

What pharmacies pay

The national acquisition cost (CMS NADAC)

The national average price a US retail pharmacy pays to acquire each product, published weekly by CMS. A wholesale floor, not the price you are charged.

Package (NDC description)Per unit
  • Menopur 75 UNIT Vial
    NDC 55566750102 · effective Sep 23, 2026

Source: CMS National Average Drug Acquisition Cost (NADAC) · as of Sep 23, 2026

Across a whole stimulation cycle, all the medications together typically total $3,000–$7,000, which is the number that matters for a budget. See the full cycle breakdown or how families pay for it.

In a cycle

When it is given

Daily subcutaneous injections during stimulation, usually combined with a recombinant FSH rather than used alone.

FDA label

What the prescribing information says

The current FDA structured product label, as published through openFDA and DailyMed. Excerpted verbatim, not summarised.

What the FDA label approves it for

1 INDICATIONS AND USAGE MENOPUR ® (menotropins for injection) is a gonadotropin indicated for: Development of multiple follicles and pregnancy in ovulatory women as part of an Assisted Reproductive Technology (ART) cycle ( 1 ) Development of Multiple Follicles and Pregnancy in Ovulatory Women as Part of an Assisted Reproductive Technology (ART) Cycle Prior to initiation of treatment with MENOPUR ® (menotropins for injection): Perform a complete gynecologic and endocrinologic evaluation, and diagnose the cause of infertility Exclude the possibility of pregnancy Evaluate the fertility status of the male partner Exclude a diagnosis of primary ovarian failure

Dosage and administration

2 DOSAGE AND ADMINISTRATION Initial starting dose of the first cycle - 225 International Units per day, administered subcutaneously ( 2.2 ) Dosage adjustments after 5 days and by no more than 150 International Units at each adjustment ( 2.2 ) Do not administer doses greater than 450 International Units per day ( 2.2 ) MENOPUR may be administered together with BRAVELLE ® (urofollitropin for injection, purified). Only the total starting dose of 225 International Units (150 International Units of MENOPUR and 75 International Units of BRAVELLE or 75 International Units of MENOPUR and 150 International Units of BRAVELLE) was studied in a clinical trial. ( 2.2 ) 2.1 General Dosing Information Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Administer MENOPUR subcutaneously in the abdomen as described in Instructions for Use. MENOPUR may be administered together with BRAVELLE ® (urofollitropin for injection, purified). 2.2 Recommended Dosing for Assisted Reproductive Technology The recommended dosing scheme for patients undergoing IVF follows a stepwise approach and is individua

Warnings and cautions

5 WARNINGS AND PRECAUTIONS MENOPUR should only be used by physicians who are experienced in infertility treatment. MENOPUR contains gonadotropic substances capable of causing in women, Ovarian Hyperstimulation Syndrome (OHSS) with or without pulmonary or vascular complications [see Warnings and Precautions (5.2 , 5.3) ] and multiple births [see Warnings and Precautions (5.5) ] . Gonadotropin therapy requires the availability of appropriate monitoring facilities [see Warnings and Precautions (5.10) ] . Use the lowest effective dose. Abnormal Ovarian Enlargement ( 5.1 ) Ovarian Hyperstimulation Syndrome (OHSS) ( 5.2 ) Pulmonary and Vascular Complications ( 5.3 ) Ovarian Torsion ( 5.4 ) Multi-fetal Gestation and Birth ( 5.5 ) Congenital Malformation ( 5.6 ) Ectopic Pregnancy ( 5.7 ) Spontaneous Abortion ( 5.8 ) Ovarian Neoplasms ( 5.9 ) 5.1 Abnormal Ovarian Enlargement In order to minimize the hazards associated with abnormal ovarian enlargement that may occur with MENOPUR therapy, treatment should be individualized and the lowest effective dose should be used [see Dosage and Administration (2.2) ] . Use of ultrasound monitoring of ovarian response and/or measurement of serum estradio

Contraindications

4 CONTRAINDICATIONS MENOPUR is contraindicated in women who exhibit: Prior hypersensitivity to MENOPUR or menotropins products or one of their excipients High levels of FSH indicating primary ovarian failure [see Indications and Usage (1) ] Pregnancy MENOPUR may cause fetal harm when administered to a pregnant woman [see Use in Specific Populations (8.1) ]. MENOPUR is contraindicated in women who are pregnant. If this drug is used during pregnancy, or if the woman becomes pregnant while taking this drug, the woman should be apprised of the potential hazard to a fetus. Presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders) [see Indications and Usage (1) ] Sex hormone dependent tumors of the reproductive tract and accessory organs Tumors of pituitary gland or hypothalamus Abnormal uterine bleeding of undetermined origin Ovarian cyst or enlargement of undetermined origin, not due to polycystic ovary syndrome MENOPUR is contraindicated in women who exhibit: Prior hypersensitivity to MENOPUR or menotropins products or one of their excipients ( 4 ) High levels of FSH indicating primary ovarian failure ( 4 ) Pregnancy ( 4 ) Presence of uncon

Label for Menopur, source: openFDA structured product labels · as of Oct 4, 2026

Reported adverse events

What has been reported to the FDA

FAERS is a voluntary reporting system. A high count reflects how widely a drug is used and how often people report, not how dangerous it is, and a report is not proof the drug caused the event.

2,088reports, all-time
1,013flagged serious
  • ovarian hyperstimulation syndrome 431
  • abdominal distension 182
  • drug ineffective 170
  • injection site pain 139
  • headache 124
  • nausea 123

Source: openFDA FAERS (drug adverse events) · as of Sep 29, 2026

Common questions

About Menopur

How much does Menopur cost?

Menopur costs $95 per 75 IU vial at Mandell's Clinical Pharmacy, the one source we found that posts a cash price (prices read Oct 4, 2026); Ferring HeartTomorrow sells it for $72.75 per 75 IU vial for elective egg freezing cycles paid in cash; a drug-price guide lists $258.05 per 75 IU vial at an ordinary retail pharmacy; pharmacies themselves pay a national average of $252.12 per vial to acquire it (CMS NADAC). Across a whole IVF cycle, all the medications together typically total $3,000 to $7,000.

Is there a savings program for Menopur?

Yes: HEART Program (Ferring): A rebate on Ferring fertility medications, including Menopur, at Ferring's in-network pharmacies. Ferring does not publish the amount. HeartTomorrow (Ferring): Menopur at $72.75 per vial, with a first fill of at least 20 vials. The coupon lasts 30 days; the offer ends December 31, 2026. Heart Beat (Ferring): Select Ferring fertility medications, including Menopur, at no cost. Heart for Heroes (Ferring): Menopur, Endometrin and Novarel 5,000 units at no cost; other medications are not covered. Each program states its own eligibility; read it on the program's page before you fill the prescription.

What is Menopur used for in fertility treatment?

Human menopausal gonadotropin, a purified urinary preparation carrying both FSH and LH activity. Often added to a recombinant FSH stimulation to supply the LH component, particularly for patients whose response to FSH alone is limited. Daily subcutaneous injections during stimulation, usually combined with a recombinant FSH rather than used alone.

How is Menopur given?

Injectable. Daily subcutaneous injections during stimulation, usually combined with a recombinant FSH rather than used alone.

Related

Other medications in a cycle

Posted cash prices are each seller's own published figure on the date shown; your price depends on the pharmacy, the quantity and your insurance. NADAC is the national average price a pharmacy pays to acquire a drug, not the price you are charged. Dosing here is quoted from the FDA label and is not a prescription: your protocol comes from your clinic. IVFcost.co is an informational data platform, not a medical provider, clinic, or laboratory. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Success rates depend heavily on individual circumstances and are not a promise of any outcome. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the clinic's own current figures.